Alzheimer's Disease Market Research Reports & Industry Analysis
A gradual loss of neurons later in adulthood does not result in significant alteration in brain function during the usual life span. However, the older one gets, the greater the neurologic impairment. Excessive neuronal degeneration in adulthood is called Alzheimer’s disease or senile dementia and is distinguished from the normal changes in aging. Alzheimer’s disease is a progressive disease which results in death of the brain cells causing memory lapses, behavioral issues, and disruption of thinking processes. The disease is considered fatal. Age and generic inheritance are the two key risk factors for developing Alzheimer’s disease. These are also risk factors that are not preventable. However, other preventable risk factors have been linked to the development of AD, including environment, diet, and overall general health. A combination of risk factors is often responsible for the disease.
Alzheimer’s disease is estimated to affect up to 6% of the population over 65. Life expectancy has been increasing around the world due to advances in healthcare, medical research, sanitation, and nutrition. This provides a setting for a higher number of Alzheimer’s disease patients in the future as the population continues to add years to their life.
Alzheimer's Disease Industry Research & Market Reports
-
United States Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032
... market was valued at $2551.32 million in 2023 and is expected to reach a revenue of $4237.32 million by 2032. MARKET INSIGHTS The United States Alzheimer’s disease therapeutics & diagnostics industry is growing rapidly, escalated ... Read More
-
Global Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032
... a CAGR of 5.81% during the forecast period 2024-2032. The base year considered for the study is 2023, and the estimated period is between 2024 and 2032. The market study has also analyzed the impact ... Read More
-
Europe Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032
... at $2105.39 million in 2023 and is expected to reach a revenue of $3594.76 million by 2032. MARKET INSIGHTS The Europe Alzheimer's disease therapeutics & diagnostics market is experiencing substantial growth due to the rising ... Read More
-
Asia-pacific Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032
... at $1686.32 million in 2023 and is expected to reach a revenue of $2905.83 million by 2032. MARKET INSIGHTS The Asia-Pacific Alzheimer's disease therapeutics & diagnostics market is experiencing substantial growth, driven by the rising ... Read More
-
North America Alzheimer’s Disease Therapeutics & Diagnostics Market Forecast 2024-2032
... was valued at $2941.34 million in 2023 and is expected to reach a revenue of $4825.00 million by 2032. MARKET INSIGHTS The North America Alzheimer's disease therapeutics & diagnostics market is expanding due to several ... Read More
-
Global Acetylcholinesterase Inhibitors Market - 2024-2031
... forecast period 2024-2031. Acetylcholinesterase inhibitors (AChEIs) are a specific kind of drug that is essential in the treatment of a variety of neurological illnesses, including Alzheimer's disease and other forms of dementia. These medications work ... Read More
-
Citicoline Market Research Report Information by Product (Capsules, Tablets, Powder, Eye Drops, and Injection) by Application (Sports Nutrition, Personal Wellness, Treatment [Glaucoma, Stroke, Alzheimer disease, Channel (pression, and Others]), by Age Group (Pediatric, Adult, and Geriatric) by Distribution Channel (Online Channel, Offline Channel), by Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032
... Geriatric) by Distribution Channel (Online Channel, Offline Channel), by Region (North America, Europe, Asia-Pacific, and Rest of the World) Industry Forecast till 2032 The Citicoline market was valued at USD 0.43 billion in 2023 and ... Read More
-
Alzheimers Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... 3.52 billion in 2022, and the market is now projected to grow from USD 3.69 billion in 2023 to USD 5.21 billion by 2030, exhibiting a CAGR of 5.1% during the forecast period of 2023-2030. ... Read More
-
Precision Psychiatry Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global precision psychiatry market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global precision ... Read More
-
Neurological Biomarkers for Alzheimer`s and Parkinson`s Diseases
... US$9.1 Billion in the year 2023, is expected to reach US$16.4 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2023-2030. The U.S. Market is Estimated at US$2.5 Billion While China ... Read More
-
Alzheimer’s Disease Drugs
... by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Donepezil, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$5.2 Billion by the ... Read More
-
Alzheimer's Drugs – A Global Market Overview
... 65 and older. It is defined by memory loss, cognitive decline, and the formation of plaques and tangles in the brain that interrupt neuron communication. Alzheimer's disease advances in phases, ranging from mild cognitive impairment ... Read More
-
Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
... Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Transmucosal Drug Delivery pipeline products with comparative analysis of the products at various stages of development and information about ... Read More
-
Blood Brain Barrier Market (3rd Edition): Industry Trends and Global Forecasts, till 2035
... period 2024-2035. The focus of blood-brain barrier drugs and technologies is to address the challenges posed by the selective nature of the blood-brain barrier, enabling therapeutic agents to reach the brain directly. Recent years have ... Read More
-
Alzheimer's Disease Market Insight, Epidemiology And Market Forecast - 2034
... 7MM is expected to increase, driven by better diagnosis and the launch of emerging therapies. DelveInsight’s analysis estimates that among the total diagnosed prevalent cases of Myotonic Dystrophy in 7MM approximately 51% of cases were ... Read More
-
Mild Cognitive Impairment Market Research Report By Disease Type (Amnestic MCI and Non-Amnestic MCI), By Age (Child, Adult, Geriatric), By Indication (Lewy Body Dementia, Parkinson’s Disease Dementia, Alzheimer’s Disease, Vascular Dementia, and Others) By Treatment (Medication (Cholinesterase Inhibitors, Benzodiazepines, Glutamate Inhibitors, Antihistamines, Mao Inhibitors, Proton Pump Inhibitors, and Others), Therapy (Cognitive Stimulation Therapy, Cognitive Behavioural Therapy (CBT)), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World – Industry Forecast Till 2032
... (Medication (Cholinesterase Inhibitors, Benzodiazepines, Glutamate Inhibitors, Antihistamines, Mao Inhibitors, Proton Pump Inhibitors, and Others), Therapy (Cognitive Stimulation Therapy, Cognitive Behavioural Therapy (CBT)), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World – ... Read More
-
Dementia Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 2025-2034. This report on global dementia drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global dementia ... Read More
-
GLP-1 Market: Industry Trends and Global Forecasts, till 2035
... Survodutide, Tirzepatide and Other Active Compounds), Type of GLP-1 Agonist Drugs (Long-acting GLP-1 Agonist and Short-acting GLP-1 Agonist), Type of Agonist (Single-agonist, Dual-agonist and Tri-agonist) Route of Administration (Oral and Parenteral), Target indication (Alzheimer’s Disease, ... Read More
-
Global Digital Brain Health Market Size, Share & Trends Analysis Report By End-user, By Region, and Segment Forecasts, 2023 - 2032
... Region, and Segment Forecasts, 2023 – 2032 Global Digital Brain Health market was valued at US $198.1 Billion in 2022 and is expected to reach ~US $400 Billion by 2032, growing at a CAGR of ... Read More
-
United States Generic Drugs Market Report By Therapeutic Area (Epilepsy, Cancers, Heart Disease, Mental Health, Diabetes, Allergies & Asthama, Chronic Obstructive Pulmonary Diesase, Alzheimer's Disease, HIV/AIDS, Crohn's colitis), Type (Branded Generics, Unbranded Generics), Drug Delivery (Oral, Dermal/Topical, Injectables, Inhalers), Age Group (Children (0-19 years), Young Adults (20-39 years), Adults (40-64 years), Seniors (Above 65 years)), Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, Online Pharmacy), Payment Type (Cash, Commercial, Medicaid, Medicare D), States and Company analysis 2024-2032
... (Oral, Dermal/Topical, Injectables, Inhalers), Age Group (Children (0-19 years), Young Adults (20-39 years), Adults (40-64 years), Seniors (Above 65 years)), Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, Online Pharmacy), Payment Type (Cash, Commercial, Medicaid, ... Read More
-
Alzheimer's Drugs Market Report by Drug Class (Cholinesterase Inhibitors NMDA Receptor Antagonist Combination Drugs and Others), Drug Type (Galantamine, Donepezil, Memantine, Rivastigmine, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Region and Company Analysis 2024-2032
... Company Analysis 2024-2032 The global Alzheimer's drug market reached US$ 6.95 Billion in 2023 and is expected to reach US$ 15.08 Billion through 2032, with a CAGR of 8.99 percent from 2024 to 2032. Alzheimer's ... Read More
-
Wearable EEG Headsets Market Size, Share & Trends Analysis Report By Application (Trauma & Surgery, Disease Diagnosis), By Product, By End-use, By Region, And Segment Forecasts, 2024 - 2030
... Trends The global wearable EEG headsets market size is expected to reach USD 244.9 million by 2030, growing at a CAGR of 10.47% from 2024 to 2030, according to a new report by Grand View ... Read More
-
Milk Beverage Market Size Outlook, 2024- by Type (Kefir, Butter Milk, Ayran, Others), Categories (Flavored Drink, Unflavored Drink), Distribution channel (Supermarkets, Convenience stores, Online Channels, Others), End User (Adult, Children, Hotels, Others)- Industry Growth, Trends, Opportunities, Share, and Companies Analysis to 2032 Report
... Opportunities, Share, and Companies Analysis to 2032 Report The Milk Beverage market is poised to register a CAGR of 6.15% between 2024 and 2032. The market growth is driven by steady demand and new product ... Read More
-
Neurodegenerative Drugs
... at a CAGR of 4.2% over the analysis period 2023-2030. Multiple Sclerosis Drugs, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$38.3 Billion by the end ... Read More
-
Argentina Alzheimer's Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032
... the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the Argentina market. Also, factors that are driving and restraining the Alzheimer’s drugs market are highlighted in the study. ... Read More
Research Assistance
